Shareholders' Equity

3 Months Ended

Sep. 30, 2025

Equity [Abstract]

Shareholders' Equity

10. Shareholders' Deficit

During the three months ended September 30, 2025, we entered into an accelerated share repurchase ("ASR") program to repurchase common shares for an aggregate purchase price of $375 million. We received an initial delivery of 2.0 million common shares using a reference price of $148.12. The program will conclude by October 31, 2025.

During the three months ended September 30, 2024, we entered into an ASR program to repurchase common shares for an aggregate purchase price of $375 million. We received an initial delivery of 2.7 million common shares using a reference price of $109.65. The program concluded on October 30, 2024 at a volume weighted average price per common share of $110.10 resulting in a final delivery of 0.7 million common shares.

We funded the repurchases with available cash. The common shares repurchased are held in treasury to be used for general corporate purposes.

Accumulated Other Comprehensive Loss

The following tables summarize the changes in the balance of accumulated other comprehensive loss by component and in total:

(in millions)	Foreign Currency Translation Adjustments		Unrealized Gain/(Loss) on Derivatives, net of tax		Accumulated Other Comprehensive Loss
Balance at June 30, 2025	$	(141)	$	(14)	$	(155)
Other comprehensive (loss)/income, before reclassifications	(4)		2		(2)
Amounts reclassified to earnings	—		(2)		(2)
Total other comprehensive loss attributable to Cardinal Health, Inc., net of tax expense of $1 million	(4)		—		(4)
Balance at September 30, 2025	$	(145)	$	(14)	$	(159)

(in millions)	Foreign Currency Translation Adjustments		Unrealized Gain/(Loss) on Derivatives, net of tax		Accumulated Other Comprehensive Loss
Balance at June 30, 2024	$	(138)	$	(29)	$	(167)
Other comprehensive income, before reclassifications	5		6		11
Amounts reclassified to earnings	—		1		1
Total other comprehensive income attributable to Cardinal Health, Inc., net of tax benefit of $5 million	5		7		12
Balance at September 30, 2024	$	(133)	$	(22)	$	(155)